This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AAPL MSFT DUK EAT PNRA

LinkedIn (LNKD) estimates, target were boosted at Morgan Stanley. Shares are now seen reaching $210, according to Morgan Stanley. Estimates also upped, given higher marketing solutions growth. Overweight rating.

Nokia (NOK) estimates, target were cut at Canaccord. Shares are now seen reaching $3.50, according to Canaccord Genuity. Estimates also reduced, as the company is likely losing market share to Samsung. Hold rating.

Monsanto (MON) price target and earnings estimates through 2014 were increased at Citi. Soybeans should drive growth starting in 2014 and the accelerated buyback is also a catalyst, said Citigroup. Price target goes to $122.

Monsanto estimates, target raised at Piper as the company is carrying a lot of momentum into the planting season. Overweight rating.

New York Community Bancorp (NYCB) estimates were reduced at Citi through 2014 to reflect a soft quarter. Lower pre-payments and margins are expected and the anticipated accretive merger is unlikely to happen, said Citigroup.

Thermo Fisher (TMO) price target increased to $87 at UBS. Industry commentary has been positive, top line momentum remains intact and productivity and capital deployment will benefit the company, said UBS.

Valent (VRX) price target and estimates were reduced given the introduction of a generic version of Zovirax Ointment, said UBS. Price target goes to $81.

>To submit a news tip, email:

Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 -1.04%
EAT $46.32 -0.96%
DUK $80.02 1.50%
MSFT $49.87 0.18%
PNRA $214.13 1.10%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs